0JZ Stock Overview
Develops minimally invasive medical devices in the field of urology and structural heart in France.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Affluent Medical SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.65 |
| 52 Week High | €2.09 |
| 52 Week Low | €1.00 |
| Beta | 0.61 |
| 11 Month Change | -8.10% |
| 3 Month Change | 10.77% |
| 1 Year Change | 58.17% |
| 33 Year Change | -74.50% |
| 5 Year Change | n/a |
| Change since IPO | -78.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0JZ | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -7.8% | -3.7% | -1.9% |
| 1Y | 58.2% | 6.6% | 12.3% |
Return vs Industry: 0JZ exceeded the German Medical Equipment industry which returned 6.7% over the past year.
Return vs Market: 0JZ exceeded the German Market which returned 12.8% over the past year.
Price Volatility
| 0JZ volatility | |
|---|---|
| 0JZ Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0JZ's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0JZ's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 63 | Sebastien Ladet | www.affluentmedical.com |
Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.
Affluent Medical SA Fundamentals Summary
| 0JZ fundamental statistics | |
|---|---|
| Market cap | €69.04m |
| Earnings (TTM) | -€17.04m |
| Revenue (TTM) | €1.30m |
53.3x
P/S Ratio-4.1x
P/E RatioIs 0JZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0JZ income statement (TTM) | |
|---|---|
| Revenue | €1.30m |
| Cost of Revenue | €2.31m |
| Gross Profit | -€1.01m |
| Other Expenses | €16.03m |
| Earnings | -€17.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | -77.99% |
| Net Profit Margin | -1,315.91% |
| Debt/Equity Ratio | 54.4% |
How did 0JZ perform over the long term?
See historical performance and comparison